J&Js Scios Unit Charged in Misbranding of Heart Dr
By Karen Gullo Thousands of feet watch July 8 (Bloomberg) -- Johnson & Johnson’s Scios unit was charged with misbranding the heart drug Natrecor Tudor watches, federal prosecutors in San Continue Reading